Investment Into the U.S. in AI, Biotech Has Dropped, Says Qiming Venture's Leung

The video discusses the impact of the US-China trade war on investment strategies, focusing on sectors like e-commerce, biotech, and AI. It highlights regulatory challenges, such as the scivias regulation and Huawei's arrest, affecting risk appetite. The video also explores how US policies may spur innovation in China, with increased R&D efforts. Global collaboration is emphasized, despite challenges. The IPO market outlook is cautiously optimistic, with a strong pipeline in various sectors. Overall, the speaker is optimistic in the medium term but cautious in the short term.

How has the trade war affected investment trends in the US compared to China?

• Investment in AI and biotech has remained stable in the US.

• Investment in AI and biotech has increased in China.

• Investment in AI and biotech has increased in the US.

• Investment in AI and biotech has decreased in the US.

What is one of the main challenges companies face due to the scivias regulation?

• Deciding whether to register or not.

• Increasing production capacity.

• Finding new markets for expansion.

• Reducing operational costs.

What is the expected impact of the Made in China 2025 initiative according to the speaker?

• It will have no impact on innovation.

• It will lead to more imports from the US.

• It will spur innovation in China.

• It will limit technological growth in China.

What has been the trend in the IPO market over the past two years?

• An increase in the number of IPOs.

• A shift from IPOs to private funding.

• A decrease in the number of IPOs.

• No change in the number of IPOs.

What is the speaker's outlook on the investment landscape in the medium term?

• Very optimistic

• Very pessimistic

• Cautiously optimistic

• Neutral